federal_register: E7-8043

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
E7-8043 Use of Ozone-Depleting Substances; Removal of Essential Use Designations; Confirmation of Effective Date Rule The Food and Drug Administration (FDA) is confirming the effective date of April 23, 2007, for the direct final rule that appeared in the Federal Register of December 7, 2006 (71 FR 70870). The direct final rule amends the regulation to remove beclomethasone, dexamethasone, fluticasone, bitolterol, salmeterol, ergotamine tartrate, and ipratropium bromide, used in oral pressurized metered- dose inhalers, from the list of essential uses of ozone-depleting substances. None of these products is currently being marketed. This document confirms the effective date of the direct final rule. 2007-04-27 2007 4 https://www.federalregister.gov/documents/2007/04/27/E7-8043/use-of-ozone-depleting-substances-removal-of-essential-use-designations-confirmation-of-effective https://www.govinfo.gov/content/pkg/FR-2007-04-27/pdf/E7-8043.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is confirming the effective date of April 23, 2007, for the direct final rule that appeared in the Federal Register of December 7, 2006 (71 FR 70870). The direct final rule amends the regulation to remove...

Links from other tables